Abstract This study presents results of selection response to Streptococcosis agalactiae (SA) resistance in a commercial stock of red tilapia (Oreochromis spp.) after one generation of selection. Families were produced… Click to show full abstract
Abstract This study presents results of selection response to Streptococcosis agalactiae (SA) resistance in a commercial stock of red tilapia (Oreochromis spp.) after one generation of selection. Families were produced from 93 males and 128 females using a nested design (1 male: 2 females). At 60 days post-hatch, 30 fish from each family were challenged by intraperitoneal injection of bacterial solution (SA strain AQSA01) at the 96 h LD50 concentration (1 × 109 CFU mL−1) and observed for 14 days. Disease-resistance was measured as a binary trait (dead/alive) and as survival time, or the number of days from challenge initiation until death. Animal and sire-dam models were applied with body weight fitted as a covariate, whereas tank and generation were treated as fixed effects. Data from 128 full-sib and 35 half-sib families was used to estimate variance components using ASREML version 4.1. Heritability estimates for the base generation (G0) were highest, 0.25 ± 0.12 for binary data on the liability scale and 0.20 ± 0.08 for days until death. Breeding candidates in G0, selected from the top 10 high-ranking families based on their estimated breeding values (EBVs), were used to produce 25 full- and six half-sib families. When data from G0 and G1 were combined, heritability estimates were 0.29 ± 0.11 and 0.27 ± 0.08 for threshold sire-dam and animal models, respectively. The realized genetic gain was 2.53 days for survival time, equivalent to about a 58% improvement from 4.3 days in the base generation. In terms of binary response, the probability that the G1 fish survived to the end of challenge period increased 10% from the base generation. This study demonstrates a significant selection potential for increased disease-resistance to S. agalactiae in red tilapia.
               
Click one of the above tabs to view related content.